Literature DB >> 21128066

Iloprost for asthma.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21128066     DOI: 10.1007/s00109-010-0705-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  7 in total

1.  Iloprost has potent anti-inflammatory properties on human monocyte-derived dendritic cells.

Authors:  T Müller; T Dürk; B Blumenthal; Y Herouy; S Sorichter; M Grimm; E Panther; S Cicko; J Norgauer; M Idzko
Journal:  Clin Exp Allergy       Date:  2010-08       Impact factor: 5.018

Review 2.  The asthma epidemic.

Authors:  Waltraud Eder; Markus J Ege; Erika von Mutius
Journal:  N Engl J Med       Date:  2006-11-23       Impact factor: 91.245

3.  Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function.

Authors:  Marco Idzko; Hamida Hammad; Menno van Nimwegen; Mirjam Kool; Nanda Vos; Henk C Hoogsteden; Bart N Lambrecht
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

Review 4.  Macrophage-derived chemokine (MDC).

Authors:  A Mantovani; P A Gray; J Van Damme; S Sozzani
Journal:  J Leukoc Biol       Date:  2000-09       Impact factor: 4.962

5.  Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation.

Authors:  Chang-Hung Kuo; Ying-Chin Ko; San-Nan Yang; Yu-Te Chu; Wei-Li Wang; Shau-Ku Huang; Huan-Nan Chen; Wan-Ju Wei; Yuh-Jyh Jong; Chih-Hsing Hung
Journal:  J Mol Med (Berl)       Date:  2010-11-18       Impact factor: 4.599

6.  The role of the CXCL10/CXCR3 system in type 1 diabetes.

Authors:  Akira Shimada; Yoichi Oikawa; Yoshifumi Yamada; Yoshiaki Okubo; Shosaku Narumi
Journal:  Rev Diabet Stud       Date:  2009-08-10

Review 7.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.